Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-Arm
Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The aim of the present clinical phase IV study is to estimate the influence of Cerebrolysin
in combination with standard therapy on the dynamics of recovery of the paretic upper limb in
patients with acute ischemic stroke.
Each patient participates in the study for 176-190 days (approximately 6 months). The
estimated duration of the study is 2 years.